We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

PolyMedix Completes Successful Phase 1B Clinical Study of Heparin Antagonist PMX-60056

News   Oct 30, 2009

 
PolyMedix Completes Successful Phase 1B Clinical Study of Heparin Antagonist PMX-60056
 
 
 

RELATED ARTICLES

How RUNX Proteins Run the Show in DNA Repair

News

A study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has revealed that RUNX proteins are integral to efficient DNA repair via the Fanconi Anemia (FA) pathway.

READ MORE

Lipid Droplets: More Than Just Fat Stores

News

Lipid droplets have been found to play critical roles in the life cycles of certain proteins involved in gene expression. Now, a new study describes how lipid droplets regulate these proteins. The research has implications for understanding what helps embryos survive and could cause us to reconsider how we look at lipid-related diseases like obesity.

READ MORE

Protein Pair Provide Immune Insight

News

An unexpected discovery in two disease-linked proteins could shed light on human immune system disorders, including a rare and often fatal childhood disease called hemophagocytic lymphohistiocytosis (HLH).



READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE